Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review-Reference-Cited by-同舟云学术

Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review

Published:2023 Issue:1 Volume:12 Page:1
ISSN:2212-5531
Container-title:International Journal of Mycobacteriology
language:en
Short-container-title:Int J Mycobacteriol

Author:

Yulistiani Yulistiani,Putra OkiNugraha,Soedarsono Soedarsono,Subay Susi

Publisher

Medknow

Subject

Infectious Diseases,Microbiology (medical)

Reference49 articles.

1. Treatment outcomes of multidrug-resistant tuberculosis patients in East Java, Indonesia: A retrospective cohort analysis;Indarti;Int J Mycobacteriol,2022

2. Mechanism of action, resistance, synergism, and clinical implications of delamanid against multidrug-resistant Mycobacterium tuberculosis;Khoshnood;Front Microbiol,2021

3. Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis;Cox;Int J Tuberc Lung Dis,2018

4. WHO consolidated guidelines on tuberculosis 2020 moving toward fully oral regimen: Should country act in hurry?;Jain;Lung India,2021

5. Ministry of Health of Indonesia Republic. Joint External Monitoring Mission for Tuberculosis. Indonesia: Ministry of Health of Indonesia Republic; 2020.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjects;Antimicrobial Agents and Chemotherapy;2024-08-28

2. Economic aspects of shortening the duration of tuberculosis treatment;The Lancet Global Health;2024-06

3. Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia;The International Journal of Mycobacteriology;2024-04

4. Treatment outcomes of fluoroquinolone-resistant multidrug-resistant tuberculosis: An implication for delamanid;Tuberculosis and Respiratory Diseases;2023-12-18